Medifast (MED) Projected to Post Quarterly Earnings on Tuesday

Medifast (NYSE:MED) is expected to issue its quarterly earnings data after the market closes on Tuesday, February 18th. Analysts expect the company to announce earnings of ($0.16) per share and revenue of $114.25 million for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.

Medifast Price Performance

NYSE:MED opened at $16.19 on Friday. The stock has a market capitalization of $177.10 million, a PE ratio of 24.53 and a beta of 1.14. Medifast has a 52 week low of $14.76 and a 52 week high of $52.96. The stock’s 50-day moving average price is $16.71 and its 200-day moving average price is $18.12. The company has a quick ratio of 2.55, a current ratio of 3.11 and a debt-to-equity ratio of 0.06.

Analysts Set New Price Targets

Separately, DA Davidson raised shares of Medifast from an “underperform” rating to a “neutral” rating and raised their target price for the stock from $16.50 to $17.00 in a research note on Tuesday, November 5th.

Medifast Company Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.